Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|12|9|696-703

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.12, Iss.9, 2015-01, pp. : 696-703

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vaccination Strategies and Immunotherapy Against Influenza

By  

Clinical Immunology, Endocrine & Metabolic Drugs, Vol. 3, Iss. 1, 2016-06 ,pp. : 25-30

Bentham Science Publishers

Access to resources Recommend Favorite

Potential of Albumin Nanoparticles as Carriers for Interferon Gamma

By Segura Sara   Espuelas Socorro   Renedo María Jesús   Irache Juan Manuel  

Drug Development and Industrial Pharmacy, Vol. 31, Iss. 3, 2005-03 ,pp. : 271-280

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of Serum Levels of Chemokines during Interferon-β Treatment in Multiple Sclerosis Patients: A 1-Year, Observational Cohort Study

By Comini-Frota Elizabeth R.  

CNS Drugs, Vol. 25, Iss. 11, 2011-11 ,pp. : 971-981

Adis International

Access to resources Recommend Favorite

The Chemokine System as a Therapeutic Target in Autoimmune Thyroid Diseases: A Focus on the Interferon-&ggr; Inducible Chemokines and their Receptor

By  

Current Pharmaceutical Design, Vol. 17, Iss. 29, 2011-10 ,pp. : 3202-3216

Bentham Science Publishers

Access to resources Recommend Favorite

Upregulation Of Interferon-Gamma-Induced Genes During Prion Infection

By Moody Laura   Herbst Allen   Aiken Judd  

Journal of Toxicology and Environmental Health, Vol. 74, Iss. 2-4, 2011-01 ,pp. : 146-153

Taylor & Francis Ltd

Access to resources Recommend Favorite